2025 Pakistan Blood Banking/Transfusion Diagnostics Database: 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Immunohematology and Screening Tests
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget. LeadingMarketResearch.com provides the 2024 supplier shares, the 2024-2029 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT
More Publications
2024 Intercept Pharmaceuticals Full-Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry
US$ 750.00
January 2025
-
2024 Imperva First Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Information Technology, Services Industry
US$ 750.00
April 2024
-
2024 Cameco Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Mining and Metals Industry
US$ 750.00
October 2024
-